These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25738160)

  • 21. Cystoid Macular Edema in Bietti's Crystalline Retinopathy.
    Saatci AO; Doruk HC; Yaman A
    Case Rep Ophthalmol Med; 2014; 2014():964892. PubMed ID: 24949209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical coherence tomography in a case of Bietti's crystalline dystrophy.
    Meyer CH; Rodrigues EB; Mennel S; Schmidt JC
    Acta Ophthalmol Scand; 2004 Oct; 82(5):609-12. PubMed ID: 15453864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bietti's crystalline retinopathy.
    Yuzawa M; Mae Y; Matsui M
    Ophthalmic Paediatr Genet; 1986 Mar; 7(1):9-20. PubMed ID: 3703493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical coherence tomographic findings in bietti's crystalline tapetoretinal dystrophy.
    Giuffrè G; Distefano MG; Di Rosa L
    Retin Cases Brief Rep; 2007; 1(4):236-8. PubMed ID: 25390988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti's crystalline dystrophy.
    Song Y; Mo G; Yin G
    Int Ophthalmol; 2013 Jun; 33(3):269-76. PubMed ID: 23242590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bietti's crystalline dystrophy in Asians: clinical, angiographic and electrophysiological characteristics.
    Fong AM; Koh A; Lee K; Ang CL
    Int Ophthalmol; 2009 Dec; 29(6):459-70. PubMed ID: 18854949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystals deposits in the anterior and posterior lens cortex in Bietti corneo-retinal dystrophy.
    Louati Y; Vaclavik V; Moulin A; Schorderet D; Munier FL; Viet Tran H
    Ophthalmic Genet; 2021 Dec; 42(6):773-779. PubMed ID: 34310258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted lipidomics uncovers oxylipin perturbations and potential circulation biomarkers in Bietti's crystalline dystrophy.
    Li Q; Wang C; Zhang S; Fu Z; Jiao X; Jin Z; Hejtmancik JF; Miao H; Qi S; Peng X
    Graefes Arch Clin Exp Ophthalmol; 2024 Jul; ():. PubMed ID: 38963460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indocyanine green angiography in Bietti's crystalline retinopathy.
    Saatci AO; Yaman A; Oner FH; Ergin MH; Cingil G
    Can J Ophthalmol; 2002 Oct; 37(6):346-51. PubMed ID: 12422917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bietti's crystalline corneoretinal dystrophy: a cross-sectional study.
    Mataftsi A; Zografos L; Millá E; Secrétan M; Munier FL
    Retina; 2004 Jun; 24(3):416-26. PubMed ID: 15187665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant.
    Nakano M; Kelly EJ; Wiek C; Hanenberg H; Rettie AE
    Mol Pharmacol; 2012 Oct; 82(4):679-86. PubMed ID: 22772592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current perspectives in Bietti crystalline dystrophy.
    García-García GP; Martínez-Rubio M; Moya-Moya MA; Pérez-Santonja JJ; Escribano J
    Clin Ophthalmol; 2019; 13():1379-1399. PubMed ID: 31440027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bietti's corneal-retinal dystrophy. A 16-year progression.
    Bernauer W; Daicker B
    Retina; 1992; 12(1):18-20. PubMed ID: 1565865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bietti's crystalline dystrophy. A 5-year progression].
    Sánchez Vicente JL; Herrador Montiel A; Díez-Garretas C; Guiote Linares JR
    Arch Soc Esp Oftalmol; 2001 May; 76(5):323-6. PubMed ID: 11373710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Swept-source Optical Coherence Tomography Angiography in a Patient with Bietti Crystalline Dystrophy Followed for Ten Years.
    İpek ŞC; Ayhan Z; Kadayıfçılar S; Saatci AO
    Turk J Ophthalmol; 2019 Apr; 49(2):106-108. PubMed ID: 31055897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UTILIZATION OF FUNDUS AUTOFLUORESCENCE, SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY, AND ENHANCED DEPTH IMAGING IN THE CHARACTERIZATION OF BIETTI CRYSTALLINE DYSTROPHY IN DIFFERENT STAGES.
    Li Q; Li Y; Zhang X; Xu Z; Zhu X; Ma K; She H; Peng X
    Retina; 2015 Oct; 35(10):2074-84. PubMed ID: 25978730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP4V2 mutations in two Japanese patients with Bietti's crystalline dystrophy.
    Gekka T; Hayashi T; Takeuchi T; Goto-Omoto S; Kitahara K
    Ophthalmic Res; 2005; 37(5):262-9. PubMed ID: 16088246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological findings in Bietti's crystalline dystrophy.
    Sen P; Ray R; Ravi P
    Clin Exp Optom; 2011 May; 94(3):302-8. PubMed ID: 21488952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and angiographic characteristics of Bietti's corneoretinal dystrophy: a case study of an 8-year-old girl].
    Chaker N; Mghaieth F; Baccouri R; Merdassi A; Turki F; El Matri L
    J Fr Ophtalmol; 2007 Jan; 30(1):39-43. PubMed ID: 17287670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bietti's crystalline fundus dystrophy.
    Francois J; De Laey JJ
    Ann Ophthalmol; 1978 Jun; 10(6):709-16. PubMed ID: 677651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.